Abstract:
A holder provided for mounting of a lathe cutter includes a carrier, a first joint seat, a second joint seat, a limit rod and a clamp member. The first and second joint seats are disposed on a first and second base of the carrier respectively. The lathe cutter is mounted between the first and second joint seats. The limit rod is inserted into a through hole of the lathe cutter, and a first and second ends of the limit rod are coupled to the first and second joint seats respectively. The clamp member is disposed on the limit rod. The clamp member and the second joint seat are provided to clamp the lathe cutter to separate the lathe cutter from the first and second bases.
Abstract:
A holder provided for mounting of a lathe cutter includes a carrier, a first joint seat, a second joint seat, a limit rod and a clamp member. The first and second joint seats are disposed on a first and second base of the carrier respectively. The lathe cutter is mounted between the first and second joint seats. The limit rod is inserted into a through hole of the lathe cutter, and a first and second ends of the limit rod are coupled to the first and second joint seats respectively. The clamp member is disposed on the limit rod. The clamp member and the second joint seat are provided to clamp the lathe cutter to separate the lathe cutter from the first and second bases.
Abstract:
The present disclosure provides a molecular marker for identifying fruiting characteristics of hermaphroditic papayas, wherein the molecular marker is selected from any of the nucleotide sequence group of SEQ ID NO: 1 to 11. This present disclosure also provides a method of using molecular markers for identifying fruiting characteristics of hermaphroditic papaya.
Abstract:
Provided herein is Bacillus amyloliquefaciens strain PMB05 used in the field of plant disease control. Inoculation of plants with the strain can increase immune responses induced by detection of fungi and/or bacteria in plant, for example, increase the production of ROS and deposition of callose. Also, the strain has the effect of promoting plant growth. Therefore, the strain and its culture filtrate of the present invention can boost plant disease resistance and promote plant growth, which can be extensively used to control plant diseases and have the potential of turning into a commodified biological control agent.
Abstract:
The present invention is directed to a recombinant fusion antigen gene, a recombinant fusion antigen protein and a subunit vaccine composition having the same against infection of porcine reproductive and respiratory syndrome virus (PRRSV). A recombinant fusion antigen gene, which encodes glycoprotein GP5 with truncated N′-terminal decoy epitope, a linker sequence and membrane protein M, followed by codon optimization, is expressed by a baculovirus expression system in vitro, thereby enhancing a yield of the recombinant fusion antigen protein. The recombinant fusion antigen protein can be applied in a subunit vaccine composition, for providing vaccinated animals with better protection ability without the risks of virulent spread and virulent recovery.
Abstract:
A feed-supplying system includes a feeder and a scale. The feeder includes a bin, a valve module and a monitoring module. The monitoring module controls the valve module to open an outlet of the bin to allow the feeder to supply feed, measures a vertical inside-bin distance, and outputs a notification when it is determined that an amount of stored feed is less than a threshold based on the distance. The scale supports the supplied feed, senses weight of a load thereon. When it is determined that an amount of the supplied feed has reached a threshold based on the weight, the monitoring module controls the valve module to close the outlet so as to stop the supply of the feed.
Abstract:
A heat assisted flip chip bonding apparatus includes a semiconductor assembly having a substrate and a chip, a heating source and a press and cover assembly having a cover element and press elements. The chip is disposed above the substrate and includes conductors which contact with conductive pads on the substrate. The heating source is provided to emit a heated light which illuminates the chip via an opening of the cover element. The press elements are located between the cover element and the semiconductor assembly and each includes an elastic unit and a pressing unit. Both ends of the elastic unit are connected to the cover element and the pressing unit respectively, and the pressing unit is provided to press a back surface of the chip.
Abstract:
A heat assisted flip chip bonding apparatus includes a semiconductor assembly having a substrate and a chip, a heating source and a press and cover assembly having a cover element and press elements. The chip is disposed above the substrate and includes conductors which contact with conductive pads on the substrate. The heating source is provided to emit a heated light which illuminates the chip via an opening of the cover element. The press elements are located between the cover element and the semiconductor assembly and each includes an elastic unit and a pressing unit. Both ends of the elastic unit are connected to the cover element and the pressing unit respectively, and the pressing unit is provided to press a back surface of the chip.
Abstract:
The present invention discloses methods of treating imbalance of plasma lipids level, fatty liver, nephritis or vascular fibrosis with M2C macrophages. The M2C macrophages used in said methods is prepared by isolating mononuclear cells from bone marrow or peripheral blood, then inducing the mononuclear cells to differentiate into M2 macrophages by macrophage colony stimulating factor (M-CSF), and then inducing the M2 macrophages to polarize into MERTK-expressing M2C macrophages by baicalin. The treatment of imbalance of plasma lipids level comprises increasing proportion of high-density lipoprotein cholesterol in plasma lipids. The invention also provides methods of treating fatty liver and nephritis in a subject in need, comprising the step of administering a therapeutically effective amount of MERTK-expressing M2C macrophages.
Abstract:
This invention provides a cell line of M2C macrophage and its applications. The cell line is derived from monocytes isolated from bone marrows and peripheral blood. The monocytes were differentiated into M2 macrophage by macrophage colony-stimulating factor (M-CSF), and then the polarization of M2C macrophage was induced by baicalin. The MERTK, PTX3, and PD-L1 expression level of the M2C macrophage are high and promote phagocytosis. Hence it can be applied to cell therapy or biological agents of immune regulation. Also, the macrophage-conditioned medium and wound dressing prepared on the M2C cell have the effects of enhancing fibroblast proliferation and angiogenesis, which can improve wound healing in medical use, and can be applied to skin care product for skin repair and rejuvenation.